Retinal Neovascularization: Clinical Trials

3 trials for Retinal Neovascularization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Unknown 1

Follow Retinal Neovascularization: new trials by email Literature Review of Retinal Neovascularization trials Research Report on Retinal Neovascularization

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
Bevacizumab Injection [Avastin] - Retinal Neovascularization, Macular Edema
Phase 4CompletedUniversity Hospital, Ghent5832013-11-222026-09-21
PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumabe, panfotocoagulation (PASCAL), panfotocoagulation (PRP) single shoot (ETDRS) - Proliferative Diabetic Retinopathy
Phase 4UnknownUniversity of Sao Paulo312012-02-012013-12-09
Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study
Ranibizumab, Saline - Diabetic Retinopathy, Retinal Neovascularisation
Phase 4CompletedMoorfields Eye Hospital NHS Foundation Trust302011-03-302020-09-09

Narrower conditions

Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Retinopathy (1)  ·  Macular Edema (1)  ·  Retinal Diseases (1)

Broader conditions

Eye Diseases (3)  ·  Metaplasia (3)  ·  Neovascularization, Pathologic (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Retinal Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Diabetic Angiopathies (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Macular Degeneration (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Retinal Degeneration (1)  ·  Vascular Diseases (1)

Interventions

Bevacizumab (1)  ·  Ranibizumab (1)  ·  Sodium Chloride (1)

Sponsors

Moorfields Eye Hospital NHS Foundation Trust (1)  ·  University Hospital, Ghent (1)  ·  University of Sao Paulo (1)

Countries

Belgium (1)  ·  Brazil (1)  ·  United Kingdom (1)

Top investigators

James W Bainbridge, MA PhD FRCOphth (1)

Results publications

PMID 33470281, PMID 37260074